Modulation of motor behaviour by NMDA- and cholecystokinin-antagonism

Amino Acids

Volumn 14, Issue 1-3, 1998, Pages 25-31

  Broberger, C ^a   Blacker, D ^a   Gimenez Llort L ^a   Herrera Marschitz, M ^a   Ogren S O ^a   Hokfelt T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cerebral cortex; Glutamate; Nucleus accumbens; Schizophrenia; Striatum

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [5 (3 AZABICYCLO[3.2.2]NON 3 YL) 2,3 DIHYDRO 1 METHYL 2 OXO 1H 1,4 BENZODIAZEPIN 3 YL] 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; DIZOCILPINE; DOPAMINE; EXCITATORY AMINO ACID; GLUTAMIC ACID; N (4 BROMOPHENYL) 3 OXO 4,5 DIPHENYL 1 PYRAZOLIDINECARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE; NEUROTRANSMITTER; PHENCYCLIDINE; PHOSPHOPROTEIN DARPP 32;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL GANGLION; BRAIN CORTEX; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; MESENCEPHALON; MOTOR ACTIVITY; NERVE PROJECTION; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSORY NERVE;

ANIMALS; CHOLECYSTOKININ; CORPUS STRIATUM; MALE; MOTOR ACTIVITY; N-METHYLASPARTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ;

EID: 0031965404     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01345238     Document Type: Conference Paper

References (34)

1. Blacker D, Broberger C, Ögren SO, Hökfelt T (1997) Cholecystokinin B receptor antagonists enhance the locomotor response to the N-methyl-D-aspartate antagonists phencylidine and dizocilpine maleate. Neuroscience 76: 1057-1067
2. Burgunder JM, Young WS III (1990) Cortical neurons expressing the cholecystokinin gene in the rat: distribution in the adult brain, ontogeny, and some of their projections. J Comp Neurol 300: 26-46
3. Fagg G, Foster AC (1983) Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9: 701-719
4. Fagg GE (1987) Phencyclidine and related drugs bind to the activated N-methyl-Daspartate receptor-channel complex in rat brain membranes. Neurosci Lett 76: 221-227
5. Fonnum F, Storm-Mathisen J, Divac I (1981) Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience 6: 863-873
6. Halpain S, Girault JA, Greengard P (1990) Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature 343: 369-372
7. Hemmings HC Jr, Greengard P, Tung HYL,Cohen P (1984) DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature 310: 503-505
8. Hendry SHC, Jones EG, Beinfeld MC (1983) Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels. Proc Natl Acad Sci 80: 2400-2404
9. Herrera-Marschitz M, Meana JJ, Hokfelt T, You ZB, Morino P, Brodin E, Ungerstedt U (1992) Cholecystokinin is released from a crossed corticostriatal pathway. Neuroreport 3: 905-908
10. B receptors in the rat brain. Mol Cell Neurosci 4: 143-154
11. Hökfelt T, Skirboll L, Rehfeld JF, Goldstein M, Markey K, Dann O (1980) A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a chole-cystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing. Neuroscience 5: 2093-2124
12. Innis RB, Snyder SH (1980) Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci 77: 6917-6921
13. Ingram SM, Krause RG, Baldino IF, Skeen LC Jr, Lewis ME (1989) Neuronal localization of cholecystokinin mRNA in the rat brain by using in situ hybridization. J Comp Neurol 287: 260-272
14. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiat 148: 1301-1308
15. Kim JS, Hassler R, Haug P, Paik KS (1977) Effect of frontal cortex ablation on striatal glutamic acid level in rat. Brain Res 132: 370-374
16. Kuroki T, Takebayashi Y, Ide K, Yonezawa Y, Tsutsumi T, Matsumoto T, Hirano M, Uchimura H (1992) Antagonism of ceruletide, a cholecystokinin analog, to the neurochemical effects of the non-competitive TV-methyl-D-aspartate (NMDA) receptor antagonists, phencyclidine and MK-801, on regional dopaminergic neurons in the rat brain. Neuropeptides 21: 167-173
17. Ladurelle N, Roques BP, Daugé V (1995) The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. J Neurosci 15: 3118-3127
18. McDonald JK, Parnavelas JG, Karamanlidis A, Brecha N, Rosenquist G (1982) The morphology and distribution of peptide-containing neurons in the adult and developing visual cortex of the rat. III. Cholecystokinin. Neurocytol 11: 881-895
19. McGeer PL, McGeer EG, Schere V, Singh K (1977) A glutamatergic corticostriatal pathway. Brain Res 128: 369-373
20. Meana JJ, Herrera-Marschitz M, Brodin E, Hökfelt T, Ungerstedt U (1991) Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis. Amino Acids 1: 365-373
21. Morino P, Herrera-Marschitz M, Meana JJ, Ungerstedt U, Hökfelt T (1992) Immunohistochemical evidence for a crossed cholecystokinin pathway in the rat. Neurosci Lett 148: 133-136
22. Morino P, Herrera-Marschitz M, Castel MN, Ungerstedt U, Varro A, Dockray C, Hökfelt T (1994) Cholecystokinin in cortico-striatal neurons in the rat: immunohistochemical studies at the light and electron microscopical level. Eur J Neurosci 6: 681-692
23. Mutt V, Jorpes JT (1968) Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur J Biochem 6: 156-162
24. Ouimet CC, Miller PE, Hemmings HC Jr, Walaas SI, Grccngard P (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4: 114-124
25. Peters A, Miller M, Kimerer LM (1983) Cholecystokinin-like immunoreactive neurons in rat cerebral cortex. III. Numerical considerations. Neuroscience 8: 431-448
26. Pettersson E, Herrera-Marschitz M, Rodriguez-Puertas R, Xu Z-Q, Hughes J, Eide RP, Ungerstedt U, Hökfelt T (1996) Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: modulation by the mesencephalic dopamine pathway via the D1 subtype of receptor. Neuroscience 74: 51-66
27. Reubi JC, Cuénod M (1979) Glutamate release in vitro from corticostriatal terminals. Brain Res 176: 185-188
28. Savasta M, Palacios JM, Mengod G (1988) Regional localization of the mRNA coding for the neuropeptide cholecystokinin in the rat brain studied by in situ hybridization. Neurosci Lett 93: 132-138
29. Snyder GL, Fisone G, Morino P, Gundersen V, Ottersen OP, Hökfelt T, Greengard P (1993) Regulation by the neuropeptide cholecystokinin (CCK-8S) of protein phosphorylation in the neostriatum. Proc Natl Acad Sci USA 90: 11277-11281
30. Vanderhaeghen JJ, Signeau P, Gepts W (1975) New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257: 604-605
31. Vanderhaeghen JJ, Lotstra F, Vierendeels G, Gilles C, Deschepper C, Verbanck P (1981) Cholecystokinins in the central nervous system and neurohypophysis. Peptides 2: 81-88
32. Wank SA, Harkins R, Jensen RT, Shapira H, deWeerth A, Slattery T (1992a) Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Nat Acad Sci USA 89: 3125-3129
33. Wank SA, Pisegna JR, deWeerth A (1992b) Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Nat Acad Sci USA 89: 8991-8995
34. You ZB, Herrera-Marschitz M, Brodin E, Meana JJ, Morino P, Hökfelt T, Silveira R, Goiny M, Ungerstedt U (1994) On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. J Neurochem 62: 76-85